These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8753319)

  • 1. [Vasoactive intestinal polypeptide (VIP)].
    Yamaguchi K; Otsubo K; Haniuda C; Miyoshi S; Abe K; Ohnami S
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():626-30. PubMed ID: 8753319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasoactive intestinal polypeptide (VIP)].
    Watanabe S
    Nihon Rinsho; 1999 Dec; 57 Suppl():329-31. PubMed ID: 10778131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasoactive intestinal polypeptide (VIP)].
    Watanabe S
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():541-3. PubMed ID: 20963892
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasoactive intestinal polypeptide (VIP)].
    Watanabe S
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():502-4. PubMed ID: 16149562
    [No Abstract]   [Full Text] [Related]  

  • 5. Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide (VIP) in man.
    Burhol PG; Lygren I; Jenssen TG; Jorde R
    Mater Med Pol; 1985; 17(1):30-3. PubMed ID: 4040993
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasoactive intestinal polypeptide (VIP) concentration after small bowel resection.
    Lezoche E
    Gastroenterology; 1978 May; 74(5 Pt 1):966. PubMed ID: 640355
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man.
    Burhol PG; Waldum HL; Jorde R; Lygren I
    Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide (VIP) plasma levels in chronic renal failure.
    Piga M; Altieri P; Floris A; Barraca A; Tagleri G; Madeddu G; Bolasco F; Gervasi F; Piras MR; Serra AR
    J Nucl Med Allied Sci; 1984; 28(2):77-80. PubMed ID: 6512602
    [No Abstract]   [Full Text] [Related]  

  • 9. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of vasoactive intestinal polypeptide, secretin, and human pancreatic polypeptide to glucose during fasting.
    Oktedalen O; Opstad PK; Jorde R; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1984 Jan; 19(1):59-64. PubMed ID: 6710078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.
    Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H
    Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of vasoactive intestinal polypeptide in liver disease.
    Hunt S; Vaamonde CA; Rattassi T; Berian G; Said SI; Papper S
    Arch Intern Med; 1979 Sep; 139(9):994-6. PubMed ID: 475538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of duodenal infusion of graded doses of HCL on plasma secretin and vasoactive intestinal polypeptide (VIP), and on duodenal bicarbonate secretion in man.
    Lygren I; Burhol PG; Waldum HL; Jorde R
    Mater Med Pol; 1980; 12(4):223-8. PubMed ID: 7266047
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of vasoactive intestinal polypeptide (VIP) in diagnosis of sleep apnea syndrome].
    Fischer J; Jackowski M
    Pneumologie; 1989 Nov; 43 Suppl 1():584-6. PubMed ID: 2608648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observation of vasoactive intestinal polypeptide in patients with trigeminal neuralgia: a 16-cases report].
    Zhao Y; Jiang X; Liu Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Feb; 20(1):33-4, 38. PubMed ID: 12593198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes.
    Danek A; O'Dorisio MS; O'Dorisio TM; George JM
    J Immunol; 1983 Sep; 131(3):1173-7. PubMed ID: 6309960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in plasma levels of vasoactive intestinal polypeptide in short bowel syndrome: experimental study.
    Martin Del Olmo JC; Carbajo Caballero MA; Blanco Alvarez JI; Audivert Mena L; Vaquero Puerta C
    Int Surg; 1998; 83(2):150-3. PubMed ID: 9851334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on plasma levels of vasoactive intestinal peptide (VIP) in patients with allergic rhinitis].
    Zhang RX
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(3):165-6, 187-8. PubMed ID: 8217299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.